CARL
Carlsmed, Inc.
18.60
+3.89 (+26.44%)
52w low 8.50
17.23 high
100.0% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 12.08M | 13.07M | 15.16M | 16.12M | 18.94M | |
| Cost of Revenue | -- | 3.21M | 3.15M | 3.56M | 3.69M | 4.40M | |
| Gross Profit | -- | 8.87M | 9.93M | 11.61M | 12.43M | 14.54M | |
| Operating Expenses | -- | 15.37M | 18.96M | 20.93M | 21.70M | 25.58M | |
| R&D | -- | 4.16M | 4.45M | 5.26M | 5.18M | 6.04M | |
| SG&A | -- | 11.21M | 14.52M | 15.66M | 16.52M | 19.54M | |
| Operating Income | -- | -6.50M | -9.04M | -9.32M | -9.28M | -11.04M | |
| EBITDA | -- | -6.34M | -8.06M | -8.19M | -8.29M | -10.07M | |
| Pretax Income | -- | -6.77M | -8.53M | -8.61M | -8.70M | -10.51M | |
| Net Income | -- | -6.77M | -8.53M | -8.61M | -8.70M | -10.51M | |
| EPS Diluted | -- | -0.26 | -0.40 | -0.32 | -0.32 | -0.39 | |
| Diluted Shares | -- | 26.52M | 21.08M | 26.60M | 26.84M | 27.19M |
Revenue CAGR
+11.9%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+17.5%